Expand GRTX Menu
GRTX MENU

GRTX Stock Summary and Trading Ideas (Galera Therapeutics | NASDAQ:GRTX)

Charts for Today's Stock Price and Implied Volatility in Galera Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for GRTX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Galera Therapeutics (GRTX) Frequently Asked Questions

What does Galera Therapeutics do?

Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The Firm's lead product candidate, avasopasem manganese, is a highly selective small molecule dismutase mimetic for severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. The Firm's second product candidate, rucosopasem manganese, has been in development to augment the anti-cancer efficacy of stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer (NSCLC) and locally advanced pancreatic cancer (LAPC).

What symbol and exchange does Galera Therapeutics stock trade?

Galera Therapeutics trades on the NASDAQ stock market under the symbol GRTX.

What is Galera Therapeutics stock price doing today?

As of April 19, 2024, GRTX stock price was flat at $0.18 with 651,963 million shares trading.

What is Galera Therapeutics's Beta?

GRTX has a beta of 0.04, meaning it tends to be less sensitive to market movements. GRTX has a correlation of 0.00 to the broad based SPY ETF.

How much is Galera Therapeutics worth?

GRTX has a market cap of $10.01 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Galera Therapeutics traded in the last 3 year period?

In the last 3 years, GRTX stock traded as high as $10.79 and as low as $.09.

What are the top ETFs holding Galera Therapeutics?

The top ETF exchange traded funds that GRTX belongs to (by Net Assets): VXF, IWC.

Is Galera Therapeutics (GRTX) a good investment?

GRTX has underperformed the market in the last year with a return of -93.3%, while the SPY ETF gained +21.2%. In the last 3 month period, GRTX fell short of the market, returning -2.6%, while SPY returned +4.3%. However, in the most recent 2 weeks GRTX has outperformed the stock market by returning +13.6%, while SPY returned -3.5%.

What is the support and resistance for Galera Therapeutics (GRTX) stock price?

GRTX support price is $.17 and resistance is $.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRTX stock will trade within this expected range on the day.